These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33865808)

  • 1. Site-selective labeling and electron paramagnetic resonance studies of human cannabinoid receptor CB
    Yeliseev AA; Zoretich K; Hooper L; Teague W; Zoubak L; Hines KG; Gawrisch K
    Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183621. PubMed ID: 33865808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor.
    Zhang Y; Xie Z; Wang L; Schreiter B; Lazo JS; Gertsch J; Xie XQ
    Int Immunopharmacol; 2011 Sep; 11(9):1303-10. PubMed ID: 21539938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities.
    Alqarni M; Myint KZ; Tong Q; Yang P; Bartlow P; Wang L; Feng R; Xie XQ
    Biochem Biophys Res Commun; 2014 Sep; 452(3):334-9. PubMed ID: 25148941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the Y
    Laugwitz JM; Haeri HH; Kaiser A; Krug U; Hinderberger D; Beck-Sickinger AG; Schmidt P
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32927734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses.
    Bouaboula M; Dussossoy D; Casellas P
    J Biol Chem; 1999 Jul; 274(29):20397-405. PubMed ID: 10400664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
    Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and motional dynamics of spin-labeled yeast iso-1-cytochrome c: 1. Stopped-flow electron paramagnetic resonance as a probe for protein folding/unfolding of the C-terminal helix spin-labeled at cysteine 102.
    Qu K; Vaughn JL; Sienkiewicz A; Scholes CP; Fetrow JS
    Biochemistry; 1997 Mar; 36(10):2884-97. PubMed ID: 9062118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial oxoglutarate carrier: structural and dynamic properties of transmembrane segment IV studied by site-directed spin labeling.
    Morozzo della Rocca B; Lauria G; Venerini F; Palmieri L; Polizio F; Capobianco L; Stipani V; Pedersen J; Cappello AR; Desideri A; Palmieri F
    Biochemistry; 2003 May; 42(18):5493-9. PubMed ID: 12731891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spin labeling analysis of structure and dynamics of the Na(+)/proline transporter of Escherichia coli.
    Wegener C; Tebbe S; Steinhoff HJ; Jung H
    Biochemistry; 2000 Apr; 39(16):4831-7. PubMed ID: 10769140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPR Techniques to Probe Insertion and Conformation of Spin-Labeled Proteins in Lipid Bilayers.
    Bordignon E; Kucher S; Polyhach Y
    Methods Mol Biol; 2019; 2003():493-528. PubMed ID: 31218631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
    Rinaldi-Carmona M; Barth F; Millan J; Derocq JM; Casellas P; Congy C; Oustric D; Sarran M; Bouaboula M; Calandra B; Portier M; Shire D; Brelière JC; Le Fur GL
    J Pharmacol Exp Ther; 1998 Feb; 284(2):644-50. PubMed ID: 9454810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct measurement of small ligand-induced conformational changes in the aspartate chemoreceptor using EPR.
    Ottemann KM; Thorgeirsson TE; Kolodziej AF; Shin YK; Koshland DE
    Biochemistry; 1998 May; 37(20):7062-9. PubMed ID: 9585515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers.
    Bingham B; Jones PG; Uveges AJ; Kotnis S; Lu P; Smith VA; Sun SC; Resnick L; Chlenov M; He Y; Strassle BW; Cummons TA; Piesla MJ; Harrison JE; Whiteside GT; Kennedy JD
    Br J Pharmacol; 2007 Aug; 151(7):1061-70. PubMed ID: 17549048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
    Gouldson P; Calandra B; Legoux P; Kernéis A; Rinaldi-Carmona M; Barth F; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 2000 Jul; 401(1):17-25. PubMed ID: 10915832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
    Griffin G; Wray EJ; Tao Q; McAllister SD; Rorrer WK; Aung MM; Martin BR; Abood ME
    Eur J Pharmacol; 1999 Jul; 377(1):117-25. PubMed ID: 10448934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs.
    Feng Z; Alqarni MH; Yang P; Tong Q; Chowdhury A; Wang L; Xie XQ
    J Chem Inf Model; 2014 Sep; 54(9):2483-99. PubMed ID: 25141027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.
    Hu J; Feng Z; Ma S; Zhang Y; Tong Q; Alqarni MH; Gou X; Xie XQ
    J Chem Inf Model; 2016 Jun; 56(6):1152-63. PubMed ID: 27186994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.
    Ndong C; O'Donnell D; Ahmad S; Groblewski T
    Eur J Pharmacol; 2011 Nov; 669(1-3):24-31. PubMed ID: 21871882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.